Proffitt & Goodson’s AbbVie ABBV Stock Holding History

Proffitt & Goodson’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	966 +48	+5%	+$10.3K	0.03%	120
2026 Q1	$200K	Hold	918	–	–	0.03%	118
2025 Q4	$210K	Hold	918	–	–	0.03%	116
2025 Q3	$213K	Sell	918 -25	-3%	-$5.09K	0.03%	110
2025 Q2	$175K	Sell	943 -4	-0.4%	-$743	0.03%	108
2025 Q1	$198K	Hold	947	–	–	0.03%	108
2024 Q4	$168K	Sell	947 -23	-2%	-$4.23K	0.03%	111
2024 Q3	$192K	Buy	970 +23	+2%	+$4.29K	0.03%	110
2024 Q2	$162K	Hold	947	–	–	0.03%	114
2024 Q1	$172K	Sell	947 -244	-20%	-$42.1K	0.03%	112
2023 Q4	$185K	Hold	1,191	–	–	0.03%	108
2023 Q3	$178K	Hold	1,191	–	–	0.04%	106
2023 Q2	$160K	Hold	1,191	–	–	0.03%	112
2023 Q1	$190K	Hold	1,191	–	–	0.04%	110
2022 Q4	$192K	Hold	1,191	–	–	0.04%	110
2022 Q3	$160K	Hold	1,191	–	–	0.03%	113
2022 Q2	$182K	Hold	1,191	–	–	0.04%	112
2022 Q1	$193K	Buy	1,191 +306	+35%	+$44.5K	0.04%	114
2021 Q4	$120K	Hold	885	–	–	0.02%	123
2021 Q3	$95K	Hold	885	–	–	0.02%	134
2021 Q2	$100K	Hold	885	–	–	0.02%	128
2021 Q1	$96K	Hold	885	–	–	0.02%	130
2020 Q4	$95K	Hold	885	–	–	0.02%	127
2020 Q3	$78K	Buy	885 +120	+16%	+$11.3K	0.02%	126
2020 Q2	$75K	Hold	765	–	–	0.02%	124
2020 Q1	$58K	Hold	765	–	–	0.02%	112
2019 Q4	$68K	Buy	+765	New	+$63.5K	0.02%	118
2019 Q3	–	Sell	-1,160	Closed	-$84K	–	209
2019 Q2	$84K	Hold	1,160	–	–	0.02%	115
2019 Q1	$93K	Buy	+1,160	New	+$94.9K	0.02%	107

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Proffitt & Goodson's ABBV Position: Q2 2026 in Review

Proffitt & Goodson increased its AbbVie (ABBV) stake by 5.2% in Q2 2026, buying an estimated $10.3K and bringing the position to 966 shares worth $243K. The position accounts for 0.03% of the portfolio, ranked #120.

Proffitt & Goodson first reported a position in ABBV in Q1 2019 and has held it in 29 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Proffitt & Goodson held 966 shares of AbbVie worth $243K as of Q2 2026.
Proffitt & Goodson bought 48 AbbVie shares in Q2 2026, an estimated $10.3K.
AbbVie made up 0.03% of Proffitt & Goodson's portfolio in Q2 2026, its #120 holding.
Proffitt & Goodson first reported a position in AbbVie in Q1 2019 and has held it in 29 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Proffitt & Goodson's 13F filing for Q2 2026, filed 22 Jul 2026.